- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Most Popular Stocks
Norwegian Pharmaceuticals & Biotech Most Popular Stocks
Results
17
Most Popular Stocks on the market
17 companies
Photocure
Market Cap: NOK 1.5b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 57.60
7D
-2.9%
1Y
9.7%
ArcticZymes Technologies
Market Cap: NOK 1.3b
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.
AZT
NOK 25.60
7D
0.4%
1Y
41.9%
Thor Medical
Market Cap: NOK 1.3b
Produces and supplies alpha-particle emitters for cancer therapy in Norway.
TRMED
NOK 3.65
7D
-16.4%
1Y
212.5%
Vistin Pharma
Market Cap: NOK 1.0b
Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.
VISTN
NOK 23.10
7D
-2.5%
1Y
-17.2%
Hofseth BioCare
Market Cap: NOK 735.8m
Produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States.
HBC
NOK 1.79
7D
-4.0%
1Y
8.5%
Nykode Therapeutics
Market Cap: NOK 532.6m
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
NYKD
NOK 1.63
7D
8.7%
1Y
-64.6%
Lytix Biopharma
Market Cap: NOK 477.8m
A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.
LYTIX
NOK 7.00
7D
-5.1%
1Y
1.7%
Norda
Market Cap: NOK 415.7m
A biotechnology company, engages in the cancer diagnostic activities.
NORD
NOK 81.00
7D
0%
1Y
95.2%
Navamedic
Market Cap: NOK 379.7m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 21.50
7D
-1.8%
1Y
-29.5%
Zelluna
Market Cap: NOK 255.7m
Develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers.
ZLNA
NOK 12.50
7D
-3.8%
1Y
n/a
SoftOx Solutions
Market Cap: NOK 187.2m
Operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.
SOFTX
NOK 0.083
7D
-2.4%
1Y
332.3%
EXACT Therapeutics
Market Cap: NOK 145.5m
A clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT).
EXTX
NOK 2.30
7D
9.5%
1Y
-60.0%
Oncoinvent
Market Cap: NOK 136.8m
A clinical stage company, develops radiopharmaceutical therapies against cancer.
ONCIN
NOK 1.40
7D
-6.7%
1Y
n/a
Arctic Bioscience
Market Cap: NOK 89.4m
A clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific.
ABS
NOK 3.33
7D
-9.8%
1Y
-76.5%
Circio Holding
Market Cap: NOK 66.4m
A biotechnology company, develops novel circular RNA and immunotherapy medicines.
CRNA
NOK 0.61
7D
-3.0%
1Y
-12.9%
BerGenBio
Market Cap: NOK 46.9m
A clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory disease in Norway.
BGBIO
NOK 1.20
7D
1.7%
1Y
-88.3%
PCI Biotech Holding
Market Cap: NOK 12.0m
A biopharmaceutical company, focuses on the development of technologies and novel therapies through its photochemical technology platform.
PCIB
NOK 0.32
7D
-5.9%
1Y
-82.6%